Mechanisms underlying acceleration of blood flow recovery in ischemic limbs by macrophage colony-stimulating factor

Stem Cells

Volumn 24, Issue 5, 2006, Pages 1274-1279

  Nakano, Keiji ^a   Adachi, Yasushi ^a   Minamino, Keizo ^a   Iwasaki, Masayoshi ^a   Shigematsu, Akio ^a   Kiriyama, Naoko ^a   Suzuki, Yasuhiro ^a   Koike, Yasushi ^a   Mukaide, Hiromi ^a   Taniuchi, Shoichiro ^a   Kobayashi, Yohnosuke ^a   Kaneko, Kazunari ^a   Ikeharaa, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Endothelial progenitor cell; Macrophage colony stimulating factor; Neovascularization; Vascular endothelial growth factor

Indexed keywords

RECOMBINANT COLONY STIMULATING FACTOR 1; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; BONE MARROW; BONE MARROW CELL; CELL MIGRATION; CONTROLLED STUDY; CONVALESCENCE; DRUG MECHANISM; DRUG POTENCY; ENDOTHELIUM CELL; FUNCTIONAL PROTEOMICS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIMB BLOOD FLOW; LIMB BLOOD VESSEL; LIMB ISCHEMIA; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; STEM CELL;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GRANULOCYTE COLONY-STIMULATING FACTOR; HINDLIMB; HUMANS; ISCHEMIA; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RECOMBINANT PROTEINS; REGIONAL BLOOD FLOW;

EID: 33749067211     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0421     Document Type: Article

References (32)

1. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
2. Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228.
3. Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: A pilot study and a randomized control trial. Lancet 2002;360:427-435.
4. Kobayashi T, Hamano K, Li TS et al. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res 2000;89:189-195.
5. Andreeff M, Welte K. Hematopoietic colony-stimulating factors. Semin Oncol 1989;16:211-229.
6. Tsuchiya M, Nomura H, Asano S et al. Characterization of recombination human granulocyte-colony stimulating factor produced in mouse cells. EMBO J 1987;6:611-616.
7. Teshima T, Harada M, Takamatsu Yet al. Granulocyte colony-stimulating factor (G-CSF)-induced mobilization of circulating haematopoietic stem cells. Br J Haematol 1993;84:570-573.
8. Schwartzberg LS, Birch R, Hazelton B et al. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J Haemathother 1992;1:317-327.
9. Kang HJ, Kim HS, Zhang SY et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 2004;363:751-756.
10. Ripa RS, Yongzhong W, Jørgensen E et al. Bone-marrow stem cell mobilization induced by granulocyte-colony stimulating factor in patients with a PCI-treated acute ST-elevated myocardial infarction is safe: Results from a double-blind randomized study, the stem cells in myocardial infarction. (STEMMI) trial (Abstract). Circulation 2004;110(suppl 3):238.
11. Pezsch M, Ince H, Kleine HD et al. No restenosis after G-CSF in acute myocardial infarction: Insights from FIRSTLINE-AMI (front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor) (Abstract). Circulation 2004;110(suppl 3):238.
12. Ince H, Petzsch M, Kleine HD et al. Prevention of LV remodeling with G-CSF in acute myocardial infarction: Insights from FIRSTLINE-AMI (front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor) (Abstract). Circulation 2004;110(suppl 3):352.
13. Minamino K, Adachi Y, Okigaki M et al. Macrophage colony-stimulating factor (M-CSF) as well as granulocyte colony-stimulating factor (G-CSF) accelerates neovascularization. STEM CELLS 2005;23:347-354.
14. Petit I, Szyper-Kravitz M, Nagler A et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002;3:687-694.
15. Amano K, Okigaki M, Adachi Y et al. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. J Mol Cell Cardiol 2004;36:469-480.
16. Iwasaki M, Adachi Y, Minamino K et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J Am Soc Nephrol 2005;16:658-666.
17. Shahin R, David L. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-712.
18. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-10934.
19. Schaper W, De Brabander M, Lewi P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res 1971;28:671-679.
20. Lindemann A, Rumberger B. Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF). Eur J Cancer 1993;29A:2338-2339.
21. Adachi K, Suzuki M, Sugimoto T et al. Effects of granulocyte colony-stimulating factor (G-CSF) on bleomycin-induced lung injury of varying severity. Toxicol Pathol 2003;31:665-673.
22. Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438.
23. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368-4380.
24. Detmar M, Yeo KT, Nagy JA et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 1995;105:44-50.
25. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18-32.
26. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
27. Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996;271:603-606.
28. Barbera-Guillem E, Nyhus JK, Wolford CC et al. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 2002;62:7042-7049.
29. Jablonska E, Puzewska W, Grabowska Z et al. VEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancer. Cytokine 2005;30:93-99.
30. Asahara T, Takahashi T, Masuda H et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-3972.
31. Strehlow K, Werner N, Berweiler J et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003;107:3059-3065.
32. Vajanto I, Rissanen TT, Rutanen J et al. Evaluation of angiogenesis and side effects in ischemic rabbit hind limbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ. J Gene Med 2002;4:371-380.